Colgate-Palmolive Company (CL)
Colgate to Aid by Innovation & Other Efforts: Should You Buy or Hold?
CL gains from strong pricing, productivity moves, and an innovation strategy that supports continued momentum.
Colgate Stock Slips 7% in a Month: What's the Best Move Now?
Colgate-Palmolive Company CL has experienced a 7.3% decrease in its share price over the past month, a notable drop that was amplified following the release of its first-quarter fiscal 2025 results. While the company, a prominent player in the consumer staples space, has a strong brand portfolio and extensive global reach, recent headwinds have weighed on investor sentiment and highlighted vulnerabilities in its business model.
Colgate-Palmolive Company (CL) Goldman Sachs Global Staples Forum (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Goldman Sachs Global Staples Forum May 13, 2025 8:15 AM ET Company Participants John Hazlin - President of Hill's Pet Nutrition John Faucher - Chief IR and EVP, M&A Conference Call Participants Bonnie Herzog - Goldman Sachs Bonnie Herzog So with that, we're excited to kick off this year's conference with Colgate, and it is my pleasure to welcome Colgate's President of Hill's Pet Nutrition, John Hazlin; and Chief IR and EVP, M&A, John Faucher to join us on stage. So John Hazlin has close to 3 decades of experience at Colgate, having served in several roles across his illustrious career at the firm.
GO vs. CL: Which Stock Should Value Investors Buy Now?
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Grocery Outlet Holding Corp. (GO) and Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?
Procter & Gamble Vs Colgate: Which is a Smarter Stock to Own Now?
With shifting consumer trends, digital expansion, cost cuts and tariff challenges, find out whether PG or CL is a better pick now.
Here's How Colgate is Poised Post Q1 Earnings: Buy or Hold the Stock?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Which Dividend King Is the Better Dividend Stock: Colgate-Palmolive (CL) or Emerson Electric (EMR)
Colgate-Palmolive and Emerson Electric are both financially solid businesses to invest in.
Colgate Q1 Earnings & Sales Beat Estimates, Organic Sales Rise 1.4%
CL posts better-than-expected first-quarter 2025 results. Results benefited from organic sales growth, robust volume and pricing performance.
Colgate-Palmolive (CL) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate: EPS Beats Estimates, Sales Dip
Colgate-Palmolive (CL 0.36%), a leading manufacturer of consumer products in Oral Care, Personal Care, Home Care, and Pet Nutrition, posted its Q1 2025 earnings on April 25, 2025. However, its GAAP revenue of $4.9 billion decreased 3.1% from Q1 2024, despite exceeding estimates by $45 million.
Colgate-Palmolive cuts full-year outlook despite earnings beat, citing tariff pressures
Colgate-Palmolive Co (NYSE:CL) has cut its full-year earnings outlook, citing the impact of tariffs and currency headwinds, even as it posted first-quarter earnings that topped Wall Street expectations thanks to improved margins. The consumer goods maker now expects full-year organic sales growth of 2% to 4%, down from a prior forecast of 3% to 5%.
Colgate-Palmolive (CL) Tops Q1 Earnings and Revenue Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.86 per share a year ago.
